Journal of Gastric Cancer

  • 제25권3호
  • /
  • Pages.478-496
  • /
  • 2025
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Patients' Preferences for Gastric Cancer Treatment: A Cross-Sectional Study on Decision-Making in Multidisciplinary Treatment Strategies

  • Tae-Han Kim (Department of Surgery, Gyeongsang National University Changwon Hospital) ;
  • In-Ho Kim (Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Seung Joo Kang (Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center) ;
  • Geum Jong Song (Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine) ;
  • Mi Ran Jung (Department of Surgery, Chonnam National University Medical School) ;
  • Hye Sook Han (Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine) ;
  • Su Youn Nam (Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University) ;
  • Seong-Ho Kong (Department of Surgery, Seoul National University Hospital and Seoul National University College of Medicine Cancer Research Institute)
  • 투고 : 2025.03.24
  • 심사 : 2025.05.15
  • 발행 : 2025.07.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Decisions regarding gastric cancer treatment affect patient outcomes and quality of life (QOL); nonetheless, factors influencing patient preferences remain unclear. This study investigated the preferences for the extent of gastrectomy, minimally invasive surgery, and adjuvant therapy while identifying the key determinants. Materials and Methods: A cross-sectional survey of 240 respondents, including patients with gastric cancer and the general population, assessed their preferences for the extent of gastrectomy, surgical modality, adjuvant therapy, palliative systemic therapy, and endoscopic therapy. Correlations between demographic variables and treatment choices were statistically analyzed. Results: Patients prioritized expert recommendations for determining the extent of gastrectomy for proximal gastric cancer and selecting the surgical modality, with recurrence risk and surgical complications being the primary considerations. In terms of adjuvant therapy, a 12-month oral regimen was preferred over a 6-month oral plus injection regimen, with survival benefit being the most valued factor. Conversely, QOL was a primary concern in palliative therapy. With respect to incomplete endoscopic submucosal dissection, electrocauterization was the preferred approach, followed by surgical resection; local recurrence risk was assigned with the highest priority, followed by concerns regarding lymph node metastasis. Men and individuals living alone had a lower risk of recurrence and lymph node metastasis. Patients undergoing gastric cancer treatment preferred shorter procedures, whereas medical personnel emphasized surgical safety and efficiency. Conclusions: Demographic and clinical factors significantly influence patient preferences. Understanding these preferences is essential for shared decision-making and personalized oncological care.

키워드

과제정보

This work was supported by The Korean Gastric Cancer Association and The Korean Cancer Management Guideline Network (KCGN), a research project supported by the Korean Ministry of Health and Welfare, 2021 commissioned task to the National Cancer Center (grant numbers: NCC-2112570-1, NCC-2112570-2, and NCC-2112570-3).

참고문헌

  1. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, 2024.
  2. Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2022;20:167-192. https://doi.org/10.6004/jnccn.2022.0008
  3. Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer 2023;26:1-25. https://doi.org/10.1007/s10120-022-01331-8
  4. Kim IH, Kang SJ, Choi W, Seo AN, Eom BW, Kang B, et al. Korean Practice Guidelines for Gastric Cancer 2024: an evidence-based, multidisciplinary approach (update of 2022 Guideline). J Gastric Cancer 2025;25:5-114. https://doi.org/10.5230/jgc.2025.25.e11
  5. Josfeld L, Keinki C, Pammer C, Zomorodbakhsch B, Hübner J. Cancer patients' perspective on shared decision-making and decision aids in oncology. J Cancer Res Clin Oncol 2021;147:1725-1732. https://doi.org/10.1007/s00432-021-03579-6
  6. Williams CP, Miller-Sonet E, Nipp RD, Kamal AH, Love S, Rocque GB. Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians. Cancer 2020;126:3534-3541. https://doi.org/10.1002/cncr.32961
  7. Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean Practice Guidelines for Gastric Cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 2023;23:3-106. https://doi.org/10.5230/jgc.2023.23.e11
  8. Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1-48. https://doi.org/10.5230/jgc.2019.19.e8
  9. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003;12:18-23. https://doi.org/10.1136/qhc.12.1.18
  10. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839-E842. https://doi.org/10.1503/cmaj.090449
  11. Gonzalez C, Espinoza M, Libuy M, Crispi F, Riquelme A, Alarid-Escudero F, et al. Utility values of health status in gastric cancer: a systematic review. Value Health Reg Issues 2025;46:101063. https://doi.org/10.1016/j.vhri.2024.101063
  12. van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C, et al. Health related quality of life following open versus minimally invasive total gastrectomy for cancer: results from a randomized clinical trial. Eur J Surg Oncol 2022;48:553-560. https://doi.org/10.1016/j.ejso.2021.08.031
  13. Hofheinz R, Clouth J, Borchardt-Wagner J, Wagner U, Weidling E, Jen MH, et al. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany. BMC Cancer 2016;16:937. https://doi.org/10.1186/s12885-016-2975-9
  14. Park DJ, Han SU, Hyung WJ, Hwang SH, Hur H, Yang HK, et al. Effect of laparoscopic proximal gastrectomy with double-tract reconstruction vs total gastrectomy on hemoglobin level and vitamin B12 supplementation in upper-third early gastric cancer: a randomized clinical trial. JAMA Netw Open 2023;6:e2256004. https://doi.org/10.1001/jamanetworkopen.2022.56004
  15. Hwang SH, Park DJ, Kim HH, Hyung WJ, Hur H, Yang HK, et al. Short-term outcomes of laparoscopic proximal gastrectomy with double-tract reconstruction versus laparoscopic total gastrectomy for upper early gastric cancer: a KLASS 05 randomized clinical trial. J Gastric Cancer 2022;22:94-106. https://doi.org/10.5230/jgc.2022.22.e8
  16. Kim TH, Ryu KW, Lee JH, Cho GS, Hyung WJ, Kim CY, et al. Operation time as a simple indicator to predict the overcoming of the learning curve in gastric cancer surgery: a multicenter cohort study. Gastric Cancer 2019;22:1069-1080. https://doi.org/10.1007/s10120-019-00948-6
  17. Manara M, Aiolfi A, Sozzi A, Cali M, Grasso F, Rausa E, et al. Short-term outcomes analysis comparing open, laparoscopic, laparoscopic-assisted, and robotic distal gastrectomy for locally advanced gastric cancer: a randomized trials network analysis. Cancers (Basel) 2024:16:1620. https://doi.org/10.3390/cancers16091620
  18. Pinker I, Pilleron S. Attitudes of healthcare professionals in treatment decision-making for older adults with cancer: a scoping review protocol. BMJ Open 2023;13:e077628. https://doi.org/10.1136/bmjopen-2023-077628
  19. Seghers PALN, Wiersma A, Festen S, Stegmann ME, Soubeyran P, Rostoft S, et al. Patient preferences for treatment outcomes in oncology with a focus on the older patient-a systematic review. Cancers (Basel) 2022;14:1147 https://doi.org/10.3390/cancers14051147
  20. Jansen SJ, Kievit), Nooij MA, de Haes JC, Overpelt IM, van Slooten H, et al. Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? Br J Cancer 200184:1577-1585. https://doi.org/10.1054/bjoc.2001.1836
  21. Rodriguez-Gomez M, Pastor-Morenc G, Ruiz-Perez I, Escriba-Agiir V, Benitez-Hidalgo V. Age- and gender-based social inequalities in palliative care for cancer patients: a systematic literature review. Front Public Health 2024;12:1421940. https://doi.org/10.3389/fpubh.2024.1421940
  22. Wang C, Qiu X, Yang X, Mao J, Li Q. Factors influencing social isolation among cancer patients: a systematic review. Healthcare (Basel) 2024;12:1042. https://doi.org/10.3390/healthcare12101042
  23. Lee H, Lee YC, Shin S, Park JC, Shin SK, Lee SK, et al. Participation and conflict in the decisionmaking process for endoscopic resection or surgical gastrectomy for early gastric cancer. J Surg Oncol 2012;106:101-106. https://doi.org/10.1002/jso.23049
  24. Melnychuk M, Vindrola-Padros C, Aitchison M, Clarke CS, Fulop NJ, Levermore C, et al. Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals. BMC Cancer 2018;18:226. https://doi.org/10.1186/s12885-018-4137-8